James W.J.W.SlaterJames W.J.W., Andrew D.A.D.ZechnichAndrew D.A.D., Dean G.D.G.HaxbyDean G.D.G., Second-Generation Antihistamines. A Comparative Review, „Drugs”, 57 (1), 1999, s. 31–47, DOI: 10.2165/00003495-199957010-00004, PMID: 9951950(ang.).
F. Estelle R.F.E.R.SimonsF. Estelle R.F.E.R., H1-Antihistamines. More relevant than ever in the treatment of allergic disorders, „The Journal of Allergy and Clinical Immunology”, 112 (4), 2003, s. S42–S52, DOI: 10.1016/S0091-6749(03)01876-1, PMID: 14530788(ang.).
FrancescaF.Levi-SchafferFrancescaF., RonR.EliasharRonR., Mast Cell Stabilizing Properties of Antihistamines, „Journal of Investigative Dermatology”, 129 (11), 2009, s. 2549–51, DOI: 10.1038/jid.2009.256, PMID: 19826448(ang.).
Gailen D.G.D.MarshallGailen D.G.D., jr., Therapeutic options in allergic disease: Antihistamines as systemic antiallergic agents, „The Journal of Allergy and Clinical Immunology”, 106 (5), 2000, s. S303–S309, DOI: 10.1067/mai.2000.110165, PMID: 11080746(ang.).
JeanJ.BousquetJeanJ., Paul vanP.CauwenbergePaul vanP., NikolaiN.KhaltaevNikolaiN., Allergic Rhinitis and Its Impact on Asthma, „The Journal of Allergy and Clinical Immunology”, 108 (5), 2001, s. S147–S334, DOI: 10.1067/mai.2001.118891, PMID: 11707753(ang.).
AnimaA.GhosalAnimaA. i inni, Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites, „Drug Metabolism Letters”, 3 (3), 2009, s. 162–170, DOI: 10.2174/187231209789352067, PMID: 19702548(ang.).
nih.gov
ncbi.nlm.nih.gov
James W.J.W.SlaterJames W.J.W., Andrew D.A.D.ZechnichAndrew D.A.D., Dean G.D.G.HaxbyDean G.D.G., Second-Generation Antihistamines. A Comparative Review, „Drugs”, 57 (1), 1999, s. 31–47, DOI: 10.2165/00003495-199957010-00004, PMID: 9951950(ang.).
F. Estelle R.F.E.R.SimonsF. Estelle R.F.E.R., H1-Antihistamines. More relevant than ever in the treatment of allergic disorders, „The Journal of Allergy and Clinical Immunology”, 112 (4), 2003, s. S42–S52, DOI: 10.1016/S0091-6749(03)01876-1, PMID: 14530788(ang.).
FrancescaF.Levi-SchafferFrancescaF., RonR.EliasharRonR., Mast Cell Stabilizing Properties of Antihistamines, „Journal of Investigative Dermatology”, 129 (11), 2009, s. 2549–51, DOI: 10.1038/jid.2009.256, PMID: 19826448(ang.).
Gailen D.G.D.MarshallGailen D.G.D., jr., Therapeutic options in allergic disease: Antihistamines as systemic antiallergic agents, „The Journal of Allergy and Clinical Immunology”, 106 (5), 2000, s. S303–S309, DOI: 10.1067/mai.2000.110165, PMID: 11080746(ang.).
JeanJ.BousquetJeanJ., Paul vanP.CauwenbergePaul vanP., NikolaiN.KhaltaevNikolaiN., Allergic Rhinitis and Its Impact on Asthma, „The Journal of Allergy and Clinical Immunology”, 108 (5), 2001, s. S147–S334, DOI: 10.1067/mai.2001.118891, PMID: 11707753(ang.).
M.S.M.S.AshenagerM.S.M.S. i inni, Inhibition of Cytokine-Induced Expression of T-cell Cytokines by Antihistamines, „Journal of Investigational Allergology and Clinical Immunology”, 17 (1), 2007, s. 20–26, PMID: 17323859(ang.).
J.M.J.M.Negro-AlvarezJ.M.J.M. i inni, Antiallergic properties of antihistamines, „Allergologia et Immunopathologia”, 24 (4), 1996, s. 177–183, PMID: 8939275(ang.).
AnimaA.GhosalAnimaA. i inni, Metabolism of Loratadine and Further Characterization of Its In Vitro Metabolites, „Drug Metabolism Letters”, 3 (3), 2009, s. 162–170, DOI: 10.2174/187231209789352067, PMID: 19702548(ang.).